Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Trine Møldrup Jakobsen1, Niklas Cyril Hansen2, Anders Hvid-Hansen2

  • 1Øjenafdelingen, Syddansk Universitetshospital - Vejle Sygehus.

Ugeskrift for Laeger
|November 29, 2023
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic Yield and Clinical Impact of Comprehensive WES/WGS Testing Beyond Common Genetic Causes in Hereditary Optic Atrophy.

Clinical genetics·2026
Same author

From oxygen to impact: Thank you, Einar Stefánsson.

Acta ophthalmologica·2026
Same author

A nationwide overview of the clinical and genetic landscape of inherited eye disorders in Denmark.

Ophthalmic genetics·2026
Same author

Sleep-wake problems and fatigue in retinitis pigmentosa: A scoping review.

Sleep medicine reviews·2026
Same author

Workforce challenges to implementation of myopia management in Europe: an electronic/telephone expert survey.

Frontiers in ophthalmology·2026
Same author

"Do not act blind": findings from qualitative interviews with adolescents and adults living with a visual impairment or blindness.

BMC public health·2026

New treatments for myopia, a condition affecting 2.6 billion globally, show promise in reducing high myopia progression. These interventions aim to decrease the future prevalence of sight-threatening myopia.

Area of Science:

  • Ophthalmology and Vision Science
  • Public Health

Background:

  • Myopia affects 2.6 billion worldwide, with increasing rates of sight-threatening high myopia (≤ -6 diopters).
  • Excessive axial elongation of the eyeball is the primary cause of myopia.
  • Current treatments focus on slowing myopia progression.

Approach:

  • This review examines emerging pharmacological and optical interventions for myopia control.
  • It synthesizes evidence on the efficacy of these novel treatments.

Key Points:

  • Increased outdoor time is recognized for delaying myopia onset.
  • New pharmacological and optical interventions are being developed to reduce myopia progression.
  • These interventions target the underlying mechanisms of axial elongation.

Related Experiment Videos

Conclusions:

  • Promising new interventions are expected to significantly decrease the future prevalence of sight-threatening high myopia.
  • These advancements offer hope for reducing the global burden of severe myopia.